AGLE

Aeglea BioTherapeutics Stock Price

7.15
-0.67 (-8.57%)
7.15
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Aeglea BioTherapeutics Inc AGLE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.67 -8.57% 7.15 17:29:17
Open Price Low Price High Price Close Price Prev Close
7.91 7.02 7.92 7.15 7.82
Bid Price Ask Price Spread News
7.00 7.60 0.60 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,658 257,842 $ 7.31 $ 1,884,717 220,345 3.50 - 11.38
Last Trade Time Type Quantity Stock Price Currency
16:50:49 average 615 $ 7.04 USD

Aeglea BioTherapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 342.75M 47.94M 44.94M $ - $ - -2.45 -4.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 2.10%

more financials information »

Aeglea BioTherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGLE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.288.177.027.64220,905-0.13-1.79%
1 Month7.748.176.957.52202,554-0.59-7.62%
3 Months7.669.786.57997.79225,096-0.51-6.66%
6 Months7.259.906.57997.85245,594-0.10-1.38%
1 Year6.5611.383.507.82234,2060.598.99%
3 Years7.2412.003.508.26174,398-0.09-1.24%
5 Years10.0012.752.817.83131,545-2.85-28.5%

Aeglea BioTherapeutics Description

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.


Your Recent History
NASDAQ
AGLE
Aeglea Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.